As of May 2022 NeoGenomics has a market cap of $1.19 Billion. This makes NeoGenomics the world's 4120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.21 B | -71.07% |
2021 | $4.20 B | -29.72% |
2020 | $5.97 B | 95.04% |
2019 | $3.06 B | 157.29% |
2018 | $1.19 B | 67.2% |
2017 | $0.71 B | 5.88% |
2016 | $0.67 B | 12.76% |
2015 | $0.59 B | 137.53% |
2014 | $0.25 B | 41.28% |
2013 | $0.17 B | 58.34% |
2012 | $0.11 B | 85.52% |
2011 | $0.06 B | 24.42% |
2010 | $0.04 B | -12.78% |
2009 | $0.05 B | 188.34% |
2008 | $0.01 B | -42.94% |
2007 | $0.03 B | -16.48% |
2006 | $0.04 B | 835.52% |
2005 | $4.33 M | -19.42% |
2004 | $5.38 M | 483.74% |
2003 | $0.92 M | -74.27% |
2002 | $3.58 M | -40.97% |
2001 | $6.07 M |
On May 18th, 2022 the market cap of NeoGenomics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | $16.37 B | 1,269.85% | ๐บ๐ธ USA |
![]() LabCorp LH | $22.69 B | 1,798.95% | ๐บ๐ธ USA |
![]() RadNet RDNT | $1.06 B | -10.69% | ๐บ๐ธ USA |
![]() Psychemedics PMD | $0.03 B | -97.05% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZ | $0.11 B | -90.46% | ๐บ๐ธ USA |